Moderate to Severe Plaque Psoriasis

4 competing products in clinical development for Moderate to Severe Plaque Psoriasis.

Pipeline by Phase

Phase 22
Phase 31
Approved1

All Products (4)

ProductCompanyStageStatusHype
KHK4827 + PlaceboKyowa KirinPhase 3Completed
40
Placebo + SCD-044_Low Dose (Dose 1) + SCD-044_Intermediate Dose (Dose 2) + SCD-044_High Dose (Dose 3)Sun PharmaceuticalPhase 2Completed
35
KHK4827-Active + KHK4827-PlaceboKyowa KirinApprovedWithdrawn
35
KHK4827 + PlaceboKyowa KirinPhase 2Completed
35